← Insider buys
ALRN

Aileron Therapeutics, Inc.

Novartis Bioventures Ltd sold $40K of Aileron Therapeutics, Inc.

10% owner

Sold$40,158
$3.17Price
12,681Shares
−1%Stake

What ALRN did after the filing

Prices for ALRN after this filing aren't in yet.

Traded Tue, Jul 31. Filed Thu, Aug 2, 12:33 PM ET, during the session. Not investment advice.